PIEDMONT INVESTMENT ADVISORS INC - RHYTHM PHARMACEUTICALS INC ownership

RHYTHM PHARMACEUTICALS INC's ticker is RYTM and the CUSIP is 76243J105. A total of 79 filers reported holding RHYTHM PHARMACEUTICALS INC in Q3 2018. The put-call ratio across all filers is - and the average weighting 2.0%.

Quarter-by-quarter ownership
PIEDMONT INVESTMENT ADVISORS INC ownership history of RHYTHM PHARMACEUTICALS INC
ValueSharesWeighting
Q2 2018$7,0002130.00%
Other shareholders
RHYTHM PHARMACEUTICALS INC shareholders Q3 2018
NameSharesValueWeighting ↓
MPM ASSET MANAGEMENT LLC 909,258$9,074,0001.96%
NEA Management Company, LLC 4,912,306$49,025,0000.99%
RA Capital Management 4,871,067$48,613,0000.86%
Samsara BioCapital, LLC 345,293$3,446,0000.67%
Endurant Capital Management LP 197,462$1,971,0000.48%
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) 1,867,467$18,637,0000.39%
ACT CAPITAL MANAGEMENT, LLC 27,500$274,0000.20%
Baker Brothers Advisors 3,863,239$38,555,0000.19%
Rock Springs Capital Management LP 627,180$6,259,0000.14%
Aquatic Capital Management LLC 4,000$40,0000.08%
View complete list of RHYTHM PHARMACEUTICALS INC shareholders